Categories
October Surprise 2024

Aromatase Inhibitors in Breast Cancer – The New England Journal of Medicine

Until recently, tamoxifen, a nonsteroidal antiestrogen, was the mainstay of endocrine treatment of breast cancer. However, new aromatase inhibitors that are many times more potent and specific than…